Recurrent abdominal pain (RAP) in children is common, with most functional in origin. Colonoscopy has sometimes been performed to exclude pathology but its role is unclear. Our aim therefore was to assess the diagnostic yield and role of colonoscopy in these children. Retrospective review of consecutive colonoscopies in a tertiary pediatric hospital between November 2011 and October 2015 was undertaken. Only those with RAP as an indication for procedure were included. Chart review of patients with pain was undertaken to ensure they fulfilled Rome IV criteria. Patient demographics, indication for procedure, and adjunct preprocedure tests were noted. Statistical analyses were performed with SPSS software. A total of 652 colonoscopies were performed, of which 68 (10%) had abdominal pain as one of the indications, and was the sole indication in 15 (2%) patients. All 68 patients had preprocedure serum inflammatory markers measured and 53% (36/68) had stool calprotectin. Positive histology was found in 10% (7/68) including Crohn disease (n ¼ 3), polyps (n ¼ 2), and microscopic colitis (n ¼ 2). The remaining 61 patients had normal colonoscopy and ileocolonic biopsies. Of the 36 patients 5 had raised fecal calprotectin, and all had abnormal histology. Serum inflammatory markers were raised in 4 patients and all also had abnormal calprotectin. No patient with isolated abdominal pain had positive histology. Rectal bleeding was the only associated indication to predict abnormal histology (P ¼ 0.019). Colonoscopy is likely not warranted in children with RAP without bleeding, weight loss, or altered bowel habit. Fecal calprotectin is useful in helping predict positive findings.
R ecurrent abdominal pain (RAP) in children is common and accounts for 2% to 4% of pediatric office visits in United States of America with worldwide prevalence of 11% to 45% (1-3). Apley and Naish's (4) original definition of RAP described at least 3 episodes sufficiently severe to affect the child's activities during 3 months in which no organic pathology was identified. More recently, Rome IV criteria in recognition that chronic pain may result from organic and functional causes, removed the requirement of no organic pathology and altered criteria to at least 4 episodes each month for at least 2 months (5) . While the etiology of RAP is potentially diverse, functional pain remains common while organic causes less frequent although some children may have both. Children with RAP have been reported to have reduced school attendance and reduced participation in extracurricular activities (6) . Parents of children with RAP have poorer mental but not physical health quality of life (7) . This combination of reduced school attendance, and poorer mental health in their parents likely drives the desire to have the pain thoroughly investigated.
The value of colonoscopy in assessing abdominal pain to exclude organic disease, however, is unclear. Existing guidelines in both adults and children do not consider isolated abdominal pain to be an indication for colonoscopy in the absence of any alarm symptoms or signs (8, 9) . Despite this, several large retrospective studies have reported abdominal pain to be the main indication in 13.8% and 31% of pediatric patients undergoing colonoscopy (10, 11) . The question whether colonoscopy is appropriate when investigating RAP has been raised in both pediatric and adult literature (12) (13) (14) . Studies in adults found no increase in pathologic findings in those fulfilling Rome III criteria for irritable bowel syndrome in the absence of alarm symptoms (12) . Similarly in pediatrics, negative endoscopy was not associated with better prognosis in patients with RAP (15) .
The aim of this study therefore was to assess the diagnostic yield and the role of colonoscopy when assessing children with RAP.
METHODS
Retrospective review of all consecutive colonoscopies performed in a tertiary pediatric center in Brisbane, Australia from November 2011 to October 2015 was undertaken. During this
What Is Known
Recurrent abdominal pain in children is common. Functional causes are more common than organic pathology. The utility of colonoscopy to investigate recurrent abdominal pain is unclear.
What Is New
No organic pathology was noted in recurrent abdominal pain in the absence of secondary symptoms. Fecal calprotectin is useful in predicting abnormality. Colonoscopy in children with isolated recurrent abdominal pain may not be warranted.
period, the center moved from an older hospital, Royal Children's Hospital, to a new hospital, Lady Cilento Children's Hospital, and it is the only pediatric hospital for 4 million people. The hospital operating room management database was used to identify patients having colonoscopy using national government health scheme codes for colonoscopy, and colonoscopy with polypectomy. Patients coded for flexible sigmoidoscopy with or without polypectomy during the same time period were also reviewed to capture incorrectly coded patients who had total colonoscopy.
All colonoscopy reports were reviewed to determine the indication for procedure. Only those with abdominal pain as an indication for colonoscopy were included. Further chart review was then undertaken of these patients to ensure that the pain was chronic and recurrent. Patients were considered to have RAP if the pain was present for at least 2 months, occurring several times each week, and affecting their activities. Patient demographics, reason for procedure, secondary indications, endoscopic findings, and histology were noted. Stool calprotectin, serum inflammatory markers Creactive protein and erythrocyte sedimentation rate, anti-tissue transglutaminase IgA (TTG), diagnosis, and duration of followup were recorded as these investigations may be helpful in suggesting organic pathology. Calprotectin >50 mg/g, C-reactive protein >5.0 mg/L, erythrocyte sedimentation rate >10 mm/h, and TTG >20 CU were considered abnormal. Any additional blood and stool testing were also noted. Ethics approval was obtained from the Children's Health Queensland Human Research Ethics Committee.
Descriptive statistics were used to describe demographics. Pearson chi squared test was used to compare frequencies of positive histology between those with only abdominal pain and abdominal pain with additional indications, and the effect of stool and blood inflammatory markers on predicting positive histology. Multiple regression analyses were undertaken to assess the significance of secondary indications and positive histology. Statistical analyses were performed using SPSS Statistics Version 23 software.
RESULTS
There were 652 colonoscopies performed during the study period, of which 10% (68/652) had abdominal pain as an indication. The most common indications for colonoscopy in the whole cohort were assessment of inflammatory bowel disease (IBD) 58% (378/ 652), rectal bleeding 10% (68/652), and abdominal pain 10% (68/ 652). Significant family history, either IBD or polyposis, was also an indicator for colonoscopy in some patients. Median age of children having colonoscopy for pain was 12 (range 2-16) years compared to 13 (range 0.4-18.2) years for all patients. Approximately 65% of those with pain were girls compared to 57% in all patients. Overall cecal intubation rate was 96.2% (628/652) and ileal intubation rate 92.4% (603/652) with confirmatory biopsies obtained in all patients who had ileal intubation.
Chart review of those with abdominal pain (n ¼ 68) confirmed all to fulfill both Apley and Rome IV criteria for RAP. All patients had been reviewed by a pediatric gastroenterologist before colonoscopy and adjunct investigations performed by the hospital pathology service. Of the patients with RAP, 22% (15/68) were performed for isolated abdominal pain, whereas the rest had additional indications including altered bowel habit, weight loss, and iron deficiency ( Table 1 ). All children with abdominal pain had additional investigations including blood and stool testing. All children with pain had serum inflammatory markers while slightly more than half had fecal calprotectin and/or celiac serology performed (Table 1) . Other blood tests performed in some children included full blood count, electrolytes, liver function tests, and iron studies, whereas additional stool tests included stool culture, microscopy, and polymerase chain reaction for bacteria, viruses, and parasites (data not shown).
Ten percent (7/68) of children with abdominal pain had positive findings at colonoscopy ( Table 2 ). These diagnoses included Crohn disease (n ¼ 3), polyps (n ¼ 2), and microscopic colitis (n ¼ 2). Rectal bleeding correlated with the presence of polyps, and was the only secondary indication significantly more likely to have positive histology (P ¼ 0.019). All other secondary indications were not statistically significant. No patient with isolated abdominal pain had positive findings at colonoscopy or on histology. Unfortunately, calprotectin was not performed in any child with isolated abdominal pain but histology including of the terminal ileum was performed in all.
Fecal calprotectin was elevated in 5 of 36 patients and all had positive histologic findings (Table 2) . Serum inflammatory markers were also raised in 4 of 5 patients with raised calprotectin and were normal in all others (Table 2) . No child presenting with rectal bleeding had elevated calprotectin or inflammatory markers. All children with Crohn disease had associated weight loss (n ¼ 3), whereas those with microscopic colitis had altered bowel habit (n ¼ 2). Celiac serology (TTG) was negative in all patients.
Positive histology was significantly more likely in patients with elevated stool calprotectin (P < 0.001) and/or raised serum inflammatory markers (P < 0.001) than in whom these were normal. On multiple regression analyses, however, these were no longer significant, and no secondary indication nor adjunct stool and blood testing found to predict positive histology.
Multiple variables were deemed to be collinear, with high correlations between variables, leading to unreliable estimates of regression coefficients.
DISCUSSION
RAP in children is common and can be debilitating for some children and families despite the absence of organic pathology. The disruption to family function and potential threat of missed organic diagnoses often drives parents and treating clinicians to investigate these children. Although colonoscopy can be part of this armamentarium of investigations, the healthcare costs and imposition of bowel preparation, sedation or anesthesia, and associated procedure risks albeit low, to the child are not inconsiderable (16) . In our cohort of consecutive colonoscopies in a tertiary pediatric center, positive histology was noted in only 10% of patients with RAP, and all had other symptoms including weight loss, altered bowel habit, or rectal bleeding. Of note, none with isolated abdominal pain had positive findings in blood or stool testing, or at colonoscopy and histology. This is similar to El-Chammas et al (13) who also found low rates of positive histology in children with functional abdominal pain. Our findings add to that study since all our patients had ileocolonic biopsies in contrast to their study where colonoscopy was performed in only 32%, and histology not obtained in all patients with functional abdominal pain (13) .
The additional symptom most likely to result in positive findings was rectal bleeding from colonic polyps. Although not reaching statistical significance, altered bowel habit and weight loss were the only other indications that resulted in positive findings. Similarly, a report from Taiwan also noted both rectal bleeding and altered bowel habit to be significant indicators in pediatric colonoscopy, resulting in diagnostic yield of 80% (17). This is not entirely surprising since both symptoms are potential ''red flags'' for IBD, which is the most common reason for pediatric colonoscopy (14, 18) . Interestingly in our cohort, patients with Crohn disease did not have rectal bleeding, although all had weight loss, which may reflect they had predominantly small intestinal disease rather than colitis and overt rectal bleeding.
Fecal calprotectin is a noninvasive screening test initially developed to predict disease flare in patients with IBD without the need for colonoscopy. It is now widely used and postulated to result in 35% reduction of endoscopic procedures in children with IBD (19) . In this cohort, all patients with abnormal fecal calprotectin had positive histology. Serum inflammatory markers were also only positive in those with raised fecal calprotectin. In our center, fecal calprotectin was used mainly as a screening tool for those suspected of having IBD because the cost of this test is not covered by the national healthcare system. It was not used in those with abdominal pain with no secondary indication, although would have been very helpful in predicting the likelihood of positive findings. Nevertheless, our entire cohort had biopsies and all with isolated pain had normal histology. It is likely that with wider use of fecal calprotectin, further reduction in the number of patients with RAP proceeding to endoscopy and/or colonoscopy will occur (16, 20) .
There are several limitations of our study including small cohort size, single-center data, possible referral bias, and being a retrospective review. Since our center is the only tertiary pediatric hospital within the state, patients with recurrent pain refractory to previous management strategies are often referred to our service. This referral bias may account for some of these children proceeding to colonoscopy despite the absence of ''red flag'' symptoms or signs, although all had been reviewed by a pediatric gastroenterologist. With increased use of calprotectin, it is likely that colonoscopy may not be warranted even in those with recurrent pain because it seems to be a good predictor of abnormal histology. An additional limitation of this study is that we only included those who had abdominal pain as an indication for procedure. This is dependent on the gastroenterologist performing the procedure noting it as an indication. It is possible that some patients with chronic pain were not included in this cohort but all would have had other indications and not just isolated pain. In contrast to previous reports, this study had very high rates of completion with high cecal and ileal intubation rates, as well as very high biopsy rates, making it very comprehensive since biopsies are arguably the most important part of a screening colonoscopy.
Despite all the patients in our cohort with RAP having ileocolonic biopsies, only 10%, were found to be abnormal; with rectal bleeding, weight loss, and altered bowel habit together with fecal calprotectin helpful in predicting abnormality. This study suggests that colonoscopy is not indicated in children with isolated RAP in the absence of warning symptoms and normal fecal calprotectin. Larger prospective studies are required to confirm our findings. 
